Reuters

07 Jun 2026, 10:11 UTC · 3h ago

Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports

Read original · https://www.reuters.com/legal/transactional/incyte-nears-up-2-billion-deal-blood-disorder-biotech-star-ft-reports-2026-06-07/

Top 2 movers · tap to explore

Story key points

1 claims · impact-rated

What matters in this story

1
Incyte Pharma is nearing a deal to acquire blood disorder drug developer Star Therapeutics for up to $2 billion. — M&A activity typically drives a significant premium for the target company and signals growth strategy/pipeline expansion for the acquirer.
+0.60

Ticker attribution

Model heads

Sentiment in this article

INCY+0.30
The company is expanding its portfolio through a strategic acquisition of a drug developer.

Relationships in this article

INCY→STAR

6 related stories

Reuters
1h ago
Banco BPM urges MPS to discuss merger to create Italy's No.2 biggest bank
- acquisition
- m and a
Read

Incyte nears up to $2 billion deal for blood disorder biotech Star, F… · News Impact Screener

Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports

What matters in this story

Sentiment in this article

Relationships in this article

Banco BPM urges MPS to discuss merger to create Italy's No.2 biggest bank

Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports

What matters in this story

Sentiment in this article

Relationships in this article

Banco BPM urges MPS to discuss merger to create Italy's No.2 biggest bank

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Hollywood workers rally against Paramount-Skydance deal

Bouygues-led consortium signs $23.44 billion deal to buy SFR from Altice France

Bouygues Telecom takes a major step forward for its future growth by signing, alongside Free-iliad Group and Orange, a Memorandum of Understanding with Altice France with a view to acquiring SFR

Medicus Pharma advances SkinJect for Gorlin syndrome – ICYMI

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports

What matters in this story

Sentiment in this article

Relationships in this article

Next reads from the same story arc

Banco BPM urges MPS to discuss merger to create Italy's No.2 biggest bank

Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports

What matters in this story

Sentiment in this article

Relationships in this article

Next reads from the same story arc

Banco BPM urges MPS to discuss merger to create Italy's No.2 biggest bank

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Hollywood workers rally against Paramount-Skydance deal

Bouygues-led consortium signs $23.44 billion deal to buy SFR from Altice France

Bouygues Telecom takes a major step forward for its future growth by signing, alongside Free-iliad Group and Orange, a Memorandum of Understanding with Altice France with a view to acquiring SFR

Medicus Pharma advances SkinJect for Gorlin syndrome – ICYMI

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS